📆 Monday, February 3
🟢 Positive Ratings:
AbbVie (ABBV) 🇺🇸🟢
Analyst: BMO Capital Markets reiterates as “OUTPERFORM”
Price Target: $208 ⤴️ $215
Analyst: Morgan Stanley reiterates as “OUTPERFORM”
Analyst: Bank of America reiterates as “BUY”
Subscribe to see more